Federated Hermes’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-360,775
Closed -$1.14M 2427
2020
Q3
$1.14M Sell
360,775
-61,294
-15% -$193K ﹤0.01% 1189
2020
Q2
$1.23M Sell
422,069
-15,888
-4% -$46.2K ﹤0.01% 1174
2020
Q1
$1.24M Sell
437,957
-98,112
-18% -$277K ﹤0.01% 1048
2019
Q4
$1.74M Sell
536,069
-77,984
-13% -$253K ﹤0.01% 1070
2019
Q3
$1.33M Sell
614,053
-15,559
-2% -$33.6K ﹤0.01% 1177
2019
Q2
$1.98M Sell
629,612
-14,005
-2% -$44K ﹤0.01% 1056
2019
Q1
$2.39M Sell
643,617
-98,827
-13% -$368K 0.01% 988
2018
Q4
$2.15M Sell
742,444
-154,542
-17% -$448K 0.01% 999
2018
Q3
$2.36M Sell
896,986
-297,001
-25% -$781K 0.01% 1032
2018
Q2
$2.79M Sell
1,193,987
-91,535
-7% -$214K 0.01% 878
2018
Q1
$3.78M Sell
1,285,522
-218,188
-15% -$641K 0.01% 716
2017
Q4
$4.12M Sell
1,503,710
-44,370
-3% -$122K 0.01% 671
2017
Q3
$5.25M Buy
1,548,080
+102,668
+7% +$348K 0.02% 557
2017
Q2
$3.57M Buy
1,445,412
+74,559
+5% +$184K 0.01% 681
2017
Q1
$3.11M Buy
1,370,853
+232,080
+20% +$527K 0.01% 733
2016
Q4
$2.41M Buy
1,138,773
+217,315
+24% +$461K 0.01% 796
2016
Q3
$3.09M Sell
921,458
-51,475
-5% -$172K 0.01% 698
2016
Q2
$3.06M Buy
972,933
+36,888
+4% +$116K 0.01% 691
2016
Q1
$3.12M Buy
936,045
+267,626
+40% +$891K 0.01% 673
2015
Q4
$2.37M Buy
668,419
+343,001
+105% +$1.21M 0.01% 794
2015
Q3
$1.64M Buy
325,418
+96,031
+42% +$483K 0.01% 939
2015
Q2
$1.48M Buy
+229,387
New +$1.48M ﹤0.01% 1033
2015
Q1
Sell
-1,770,133
Closed -$13.6M 2142
2014
Q4
$13.6M Buy
1,770,133
+1,520
+0.1% +$11.7K 0.04% 369
2014
Q3
$13.2M Buy
1,768,613
+790,904
+81% +$5.91M 0.04% 374
2014
Q2
$9.46M Buy
977,709
+571,494
+141% +$5.53M 0.03% 470
2014
Q1
$3.38M Buy
406,215
+398,393
+5,093% +$3.31M 0.01% 769
2013
Q4
$66K Sell
7,822
-806
-9% -$6.8K ﹤0.01% 1635
2013
Q3
$69K Sell
8,628
-5,955
-41% -$47.6K ﹤0.01% 1600
2013
Q2
$113K Buy
+14,583
New +$113K ﹤0.01% 1512